A detailed history of Bochk Asset Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Bochk Asset Management LTD holds 11,900 shares of LLY stock, worth $9.32 Million. This represents 3.14% of its overall portfolio holdings.

Number of Shares
11,900
Previous 15,050 20.93%
Holding current value
$9.32 Million
Previous $13.6 Billion 22.63%
% of portfolio
3.14%
Previous 4.46%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$772.14 - $960.02 $2.43 Million - $3.02 Million
-3,150 Reduced 20.93%
11,900 $10.5 Billion
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $2.25 Million - $2.82 Million
3,100 Added 25.94%
15,050 $13.6 Billion
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $532,980 - $713,052
900 Added 8.14%
11,950 $9.3 Billion
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $5.8 Million - $6.84 Million
11,050 New
11,050 $6.44 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bochk Asset Management LTD Portfolio

Follow Bochk Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bochk Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bochk Asset Management LTD with notifications on news.